Recent advances from COVID-19 vaccine development put pharma in place to further grow relationship with patients.
Dharmendra Sahay
Advertisement
Principal, ZS
Articles by Dharmendra Sahay
A look at how UCB is utilizing dynamic targeting via AI to improve overall patient experience.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
ANI Pharmaceuticals to Acquire Egetis Therapeutics, Egetis Sells Priority Review Voucher for $190 Million
2
Why Leronlimab Isn’t Just Another Repurposed Drug: Q&A with Dr. Jay Lalezari
3
Pharmaceutical Executive Daily: Nxera Licenses EP4 Agonist to AbbVie
4
What Does a Positive Reading for Leronlimab Mean for How the Industry Thinks About Repurposing Old Biologics Into Oncology?
5